A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency
- PMID: 7025500
A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency
Similar articles
-
A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.Br J Clin Pract. 1981 Feb;35(2):79-81. Br J Clin Pract. 1981. PMID: 7020736 Clinical Trial. No abstract available.
-
[Dose-response study with O-(beta-hydroxyethyl)-rutoside oral solution].Vasa. 1987;16(4):365-9. Vasa. 1987. PMID: 3321740 Clinical Trial. German. No abstract available.
-
Paroven in the treatment of chronic venous insufficiency.Practitioner. 1979 Dec;223(1338):838-41. Practitioner. 1979. PMID: 396527 Clinical Trial. No abstract available.
-
Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.Angiology. 2000 Mar;51(3):197-205. doi: 10.1177/000331970005100303. Angiology. 2000. PMID: 10744007 Review.
-
Paroven: not much effect in trials.Drug Ther Bull. 1992 Jan 20;30(2):7-8. Drug Ther Bull. 1992. PMID: 1555498 Review. No abstract available.
Cited by
-
Phlebotonics for venous insufficiency.Cochrane Database Syst Rev. 2020 Nov 3;11(11):CD003229. doi: 10.1002/14651858.CD003229.pub4. Cochrane Database Syst Rev. 2020. PMID: 33141449 Free PMC article.
-
Drug treatment of chronic venous insufficiency and venous ulceration: a review.J R Soc Med. 1991 Jun;84(6):354-8. doi: 10.1177/014107689108400616. J R Soc Med. 1991. PMID: 2061904 Free PMC article. Review.
-
Time course of the anti-oedematous effect of O-(beta-hydroxyethyl)-rutosides in healthy volunteers.Eur J Clin Pharmacol. 1991;40(6):625-7. doi: 10.1007/BF00279983. Eur J Clin Pharmacol. 1991. PMID: 1884746 Clinical Trial.
-
Uptake and localisation of O-(beta-hydroxyethyl)-rutosides in the venous wall, measured by laser scanning microscopy.Eur J Clin Pharmacol. 1992;43(4):423-6. doi: 10.1007/BF02220620. Eur J Clin Pharmacol. 1992. PMID: 1451724 Clinical Trial.
-
Double-blind plethysmographic study of venous effects of heptaminol adenosine phosphate in patients with primary varicose veins.Eur J Clin Pharmacol. 1989;37(1):37-40. doi: 10.1007/BF00609421. Eur J Clin Pharmacol. 1989. PMID: 2591460 Clinical Trial.